Growth hormone (GH) and brain trauma

Hormones and Behavior

Volumn 63, Issue 2, 2013, Pages 331-344

  Devesa, Jesús ^a,b   Reimunde, Pedro ^b,c   Devesa, Pablo ^a,b   Barberá, Matías ^b   Arce, Víctor ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Medical Center Proyecto Foltra   (Spain)

^c UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

Amaurosis; Cognitive disorders; GH; Hemi tetraplegia; IGF 1; Neurogenic dysphagia; Physiotherapy; Remyelination; TBI; Visual stimulation

Indexed keywords

HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; BLINDNESS; CHILD; CLINICAL ARTICLE; COGNITIVE DEFECT; COGNITIVE REHABILITATION; DRUG DOSE INCREASE; DRUG EFFICACY; DYSPHAGIA; FEMALE; FUNCTIONAL ASSESSMENT; GROWTH HORMONE DEFICIENCY; HUMAN; INFORMED CONSENT; MALE; MORNING DOSAGE; MOTOR DYSFUNCTION; NEUROGENIC DYSPHAGIA; OCCUPATIONAL THERAPY; PERSISTENT VEGETATIVE STATE; PHYSIOTHERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOMOTOR PERFORMANCE; REHABILITATION CARE; REVIEW; SPEECH THERAPY; TRAUMATIC BRAIN INJURY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VISUAL ACUITY; VISUAL STIMULATION;

ACCIDENTS, TRAFFIC; ADOLESCENT; ADULT; ANIMALS; BRAIN INJURIES; CHILD; FEMALE; GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84872876580     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2012.02.022     Document Type: Review

References (107)

1. Aberg M.A., Aberg N.D., Hedbacker H., Oscarsson J., Eriksson P.S. Peripheral infusion of IGF-1 selectively induces neurogenesis in the adult rat hippocampus. J. Neurosci. 2000, 20:2896-2903.
2. Aberg N.D., Johansson U.E., Aberg M.A., et al. Peripheral infusion of insulin-like growth factor-1 increases the number of newborn oligodendrocytes in the cerebral cortex of adult hypophysectomized rats. Endocrinology 2007, 148:3765-3772.
3. Aberg N.D., Johansson I., Aberg M.A., et al. Peripheral administration of GH induces cell proliferation in the brain of adult hypophysectomized rats. J. Endocrinol. 2009, 201:141-150.
4. Ajo R., Cacicedo L., Navarro C., Sanchez-Franco F. Growth hormone action on proliferation and differentiation of cerebral cortical cells from fetal rat. Endocrinology 2003, 144:1086-1097.
5. Anderson M.F., Aberg M.A., Nilsson M., Eriksson P.S. Insulin-like growth factor-I and neurogenesis in the adult mammalian brain. Brain Res. Dev. Brain Res. 2002, 134:115-122.
6. Baudet M.L., Rattray D., Martin B.T., Harvey S. Growth hormone promotes axon growth in the developing nervous system. Endocrinology 2009, 150:2758-2766.
7. Bliss T., Guzman R., Daadi M., Steinberg G.K. Cell transplantation therapy for stroke. Stroke 2007, 38(2 Suppl.):817-826.
8. Byts N., Samoylenko A., Fasshauer T., et al. Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin. Cell Death Differ. 2008, 15:783-792.
9. Byts N., Sirén A.L. Erythropoietin: a multimodal neuroprotective agent. Exp. Transl. Stroke Med. 2009, 1:4-11.
10. Calza L., Giuliani A., Fernandez M., Pirondi S., DIntino G., Aloe L., Giardino L. Neural stem cells and cholinergic neurons: regulation by immunolesion and treatment with mitogens, retinoic acid, and nerve growth factor. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:7325-7330.
11. Chen J., Li Y., Wang L., Lu M., Zhang X., Chopp M. Therapeutic benefit of intracerebral administration of bone marrow stromal cells after cerebral ischemia in rats. J. Neurol. Sci. 2001, 189:49-57.
12. Chen Z.Y., Asavaritikrai P., Prchal J.T., Noguchi C.T. Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation. J. Biol. Chem. 2007, 282:25875-25883.
13. Christophidis L.J., Gorba T., Gustavsson M., et al. Growth hormone receptor immunoreactivity is increased in the subventricular zone of juvenile rat brain after focal ischemia: a potential role for growth hormone in injury-induced neurogenesis. Growth Horm. IGF Res. 2009, 19:497-506.
14. Costoya J.A., Finidori J., Moutoussamy S., Señarís R., Devesa J., Arce V. Activation of growth hormone receptor delivers an antiapoptotic signal: evidence for a role of Akt in this pathway. Endocrinology 1999, 140:5937-5943.
15. D'Ercole A.J., Ye P., Calikoglu A.S., Gutierrez-Ospina G. The role of the insulin-like growth factors in the central nervous system. Mol. Neurobiol. 1996, 13:227-255.
16. D'Ercole A.J., Ye P. Minireview: expanding the mind: insulin-like growth factor I and brain development. Endocrinology 2008, 149:5958-5962.
17. David Aberg N., Lind J., Isgaard J., Georg K.H. Peripheral growth hormone induces cell proliferation in the intact adult rat brain. Growth Horm. IGF Res. 2010, 20:264-269.
18. Devesa J., Lima L., Tresguerres J.A. Neuroendocrine control of growth hormone secretion in humans. Trends Endocrinol. Metab. 1992, 3:175-183.
19. Devesa J., Reimunde P., Devesa A., et al. Recovery from neurological sequelae secondary to oncological brain surgery in an adult growth hormone-deficient patient after growth hormone treatment. J. Rehabil. Med. 2009, 41:775-777.
20. Devesa J., Devesa P., Reimunde P. [Growth hormone revisited]. Med. Clin. (Barc) 2010, 6:413-418.
21. Devesa J., Alonso B., Casteleiro N., et al. Effects of recombinant growth hormone (GH) replacement and psychomotor and cognitive stimulation in the neurodevelopment of GH-deficient (GHD) children with cerebral palsy: a pilot study. Ther. Clin. Risk Manag. 2011, 7:199-206.
22. Devesa P., Reimunde P., Gallego R., Devesa J., Arce V. Growth hormone (GH) treatment may cooperate with locally-produced GH in increasing the proliferative response of hippocampal progenitors to kainate-induced injury. Brain Inj. 2011, 25:503-510.
23. Devesa P., 2011c. Effects of growth hormone on the central and peripheral neural repair. Ph.D. Thesis. University of Santiago de Compostela. Spain.
24. Devesa P., Gelabert M., González-Mosquera T., et al. Growth hormone (GH) treatment enhances the functional recovery of sciatic nerves after transection and repair. Muscle Nerve 2012, 45:385-392.
25. Donahue C.P., Jensen R.V., Ochiishi T., et al. Transcriptional profiling reveals regulated genes in the hippocampus during memory formation. Hippocampus 2002, 12:821-833.
26. Donahue C.P., Kosik K.S., Shors T.J. Growth hormone is produced within the hippocampus where it responds to age, sex, and stress. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:6031-6036.
27. Drago J., Murphy M., Carroll S.M., Harvey R.P., Bartlett P.F. Fibroblast growth factor-mediated proliferation of central nervous system precursors depends on endogenous production of insulin-like growth factor I. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:2199-2203.
28. During M.J., Cao L., Zuzga D.S., et al. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat. Med. 2003, 9:1173-1179.
29. Dutheil S., Lacour M., Tighilry B. Discovering a new functional neurogenic zone-the vestibular nuclei of the brainstem. Med Sci (Paris) 2011, 27:605-613.
30. Falleti M.G., Maruff P., Burman P., Harris A. The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: a meta-analysis of the current literature. Psychoneuroendocrinology 2006, 31:681-691.
31. García-Aragón J., Lobie P.E., Muscat G.E., Gobius K.S., Norstedt G., Waters M.J. Prenatal expression of the growth hormone (GH) receptor/binding protein in the rat: a role for GH in embryonic and fetal development?. Development 1992, 114:869-876.
32. Garcia-Segura L.M., Perez J., Pons S., Rejas M.T., Torres-Aleman I. Localization of insulin-like growth factor I (IGF-I)-like immunoreactivity in the developing and adult rat brain. Brain Res. 1991, 560:167-174.
33. Gilman C.P., Perry T., Furukawa K., Grieg N.H., Egan J.M., Mattson M.P. Glucagon-like peptide 1 modulates calcium responses to glutamate and membrane depolarization in hippocampal neurons. J. Neurochem. 2003, 87:1137-1144.
34. Gonzalez-Perez O., Alvarez-Buylla A. Oligodendrogenesis in the subventricular zone and the role of epidermal growth factor. Brain Res. Rev. 2011, 67:147-156.
35. Hatton J., Rapp R.P., Kudsk K.A., et al. Intravenous insulin-like growth factor-I (IGF-I) in moderate-to-severe head injury: a phase II safety and efficacy trial. Neurosurg. Focus. 1997, 2. ECP1.
36. Heile A., Brinker T. Clinical translation of stem cell therapy in traumatic brain injury: the potential of encapsulated mesenchymal cell biodelivery of glucagon-like peptide-1. Dialogues Clin. Neurosci. 2011, 13:279-286.
37. High W.M., Briones-Galang M., Clark J.A., et al. Effect of growth hormone replacement therapy on cognition after traumatic brain injury. J Neurotrauma. 2010, 27:1565-1575.
38. House J.W., Brackmann D.E. Facial nerve grading system. Otolaryngol. Head Neck Surg. 1985, 93:146-147.
39. Huo R., Burden S.K., Hoyt C.S., Good W.V. Chronic visual impairment in children: aetiology, prognosis, and associated neurological deficits. Br. J. Ophthalmol. 1999, 83:670-675.
40. Hyder A.A., Wunderlich C.A., Puvanachandra P., Gururaj G., Kobusingye O.C. The impact of traumatic brain injuries: a global perspective. Neuro Rehabil. 2007, 22:341-353.
41. Hydman J., Remahl S., Bjorck G., Svensson M., Mattsson P. Nimodipine improves reinnervation and neuromuscular function after injury to the recurrent laryngeal nerve in the rat. Ann. Otol. Rhinol. Laryngol. 2007, 116:623-630.
42. Isshiki N. Progress in laryngeal framework surgery. Acta Otolaryngol. 2000, 120:120-127.
43. Johansson B.B. Current trends in stroke rehabilitation. A review with focus on brain plasticity. Acta Neurol. Scand. 2011, 123:147-159.
44. Koechling T., Khalique H., Sundström E., Avila J., Lim F. A culture model for neurite regeneration of human spinal cord neurons. J. Neurosci. Methods 2011, 201:346-354.
45. Kokshoorn N.E., Smit J.W., Nieuwlaat W.A., et al. Low prevalence of hypopituitarism after traumatic brain injury: a multicenter study. Eur. J. Endocrinol. 2011, 165:225-231.
46. Laron Z., Klinger B. Laron syndrome: clinical features, molecular pathology and treatment. Horm. Res. 1994, 42:198-202.
47. Laron Z. Consequences of not treating children with Laron syndrome (primary growth hormone insensitivity). J. Pediatr. Endocrinol. Metab. 2001, Suppl. 5:1243-1248.
48. Li R.C., Guo S.Z., Raccurt M., Moudilou E., et al. Exogenous growth hormone attenuates cognitive deficits induced by intermittent hipoxia in rats. Neuroscience 2011, 196:237-250.
49. Lichtenwalner R.J., Forbes M.E., Sonntag W.E., Riddle D.R. Adult-onset deficiency in growth hormone and insulin-like growth factor-1 decreases survival of dentate granule neurons: insights into the regulation of adult hippocampal neurogenesis. J. Neurosci. Res. 2006, 83:199-210.
50. Lim M., Soul J.S., Hansen R.M., Mayer D.L., Moskowitz A., Fulton A.B. Development of visual acuity in children with cerebral visual impairment. Arch Ophtalmol 2005, 123:1215-1220. (Paris).
51. Lobie P.E., Garcia-Aragon J., Lincoln D.T., Barnard R., Wilcox J.N., Waters M.J. Localization and ontogeny of growth hormone receptor gene expression in the central nervous system. Brain Res. Dev. Brain Res. 1993, 74:225-233.
52. Longhi L., Zanier E.R., Royo N., Stochetti N., McINtosh T.K. Stem cell transplantation as a therapeutic strategy for traumatic brain injury. Transpl. Immunol. 2005, 15:143-148.
53. Lyuh E., Kim H.J., Kim M., et al. Dose-specific or dose-dependent effect of growth hormone treatment on the proliferation and differentiation of cultured neuronal cells. Growth Horm. IGF Res. 2007, 17:315-322.
54. Maruff P., Falleti M. Cognitive function in growth hormone deficiency and growth hormone replacement. Horm. Res. 2005, 64(Suppl. 3):100-108.
55. McLenachan S., Lum M.G., WAters M.J., Turnley A.M. Growth hormone promotes proliferation of adult neurosphere cultures. Growth Hormone IGF Res. 2009, 19:212-218.
56. Möderscheim T.A., Christophidis L.J., Williams C.E., Scheepens A. Distinct neuronal growth hormone receptor ligand specificity in the rat brain. Brain Res. 2007, 1137:29-34.
57. Monfort, M., Juárez, A., 2001. Test de Inteligibilidad. Maruf and Juárez (eds.) Editorial Entha. Madrid.
58. Moreau O., Yollin E., Merlen E., Daveluy W., Rousseaux M. Lasting pituitary hormone deficiency after traumatic brain injury. J. Neurotrauma 2011, 29:81-89.
59. Mori Y., Shiotani A., Saito K., et al. A novel drug therapy for recurrent laryngeal nerve injury using T-588. Laryngoscope 2007, 117:1313-1318.
60. Nieves-Martinez E., Sonntag W.E., Wilson A., et al. Early-onset GH deficiency results in spatial memory impairment in midlife and is prevented by GH supplementation. J. Endocrinol. 2010, 204:31-36.
61. Ohtaki H., Ylostalo J.H., Foraker J.E., et al. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc. Natl. Acad. Sci. U. S. A. 2008, 195:14638-14643.
62. Pan S.N., Ma H.M., Su Z., Zhang C.X., Zhu S.Y., Du M.L. Epidermal growth factor receptor signaling mediates growth hormone-induced growth of chondrocytes from sex hormone-inhibited adolescent rats. Clin. Exp. Pharmacol. Physiol. 2011, 38:534-542.
63. Pan W., Yu Y., Cain C.M., Nybeg F., Couraud P.O., Kastin A.J. Permeation of growth hormone across the blood-brain-barrier. Endocrinology 2005, 146:4898-4904.
64. Parent J.M. Injury-induced neurogenesis in the adult mammalian brain. Neuroscientist 2003, 9:261-272.
65. Pathipati P., Surus A., Williams C.E., Scheepens A. Delayed and chronic treatment with growth hormone after endothelin-induced stroke in the adult rat. Behav. Brain Res. 2009, 204:93-101.
66. Pathipati P., Gorba T., Scheepens A., Goffin V., Sun Y., Fraser M. Growth hormone and prolactin regulate human neural stem cell regenerative activity. Neuroscience 2011, 190:409-427.
67. Perry T., Lahiri D.K., Sambamurti K., et al. Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron. J. Neurosci. Res. 2003, 72:603-612.
68. Popken G.J., Dechert-Zeger M., Ye P., D'Ercole A.J. Brain development. Adv. Exp. Med. Biol. 2005, 567:187-220.
69. Reimunde P., Rodicio C., López N., Alonso A., Devesa P., Devesa J. Effects of recombinant growth hormone replacement and physical rehabilitation in recovery of gross motor function in children with cerebral palsy. Ther. Clin. Risk Manag. 2010, 30:585-592.
70. Reimunde P., Quintana A., Castañón B., et al. Effects of growth hormone (GH) replacement and cognitive rehabilitation in patients with cognitive disorders after traumatic brain injury. Brain Inj. 2011, 25:65-73.
71. Robel S., Berninger B., Götz M. The stem cell potential of glia: lessons from reactive gliosis. Nat. Rev. Neurosci. 2011, 12:88-104.
72. Romanko M.J., Rola R., Fike J.R., et al. Roles of the mammalian subventricular zone in cell replacement after brain injury. Prog. Neurobiol. 2004, 74:77-99.
73. Russo V.C., Gluckman P.D., Feldman E.L., Werther G.A. The insulin-like growth factor system and its pleiotropic functions in brain. Endocr. Rev. 2005, 26:916-943.
74. Saito K., Shiotani A., Watabe K., Moro K., Fukuda H., Ogawa K. Adenoviral GDNF gene transfer prevents motoneuron loss in the nucleus ambiguus. Brain Res. 2003, 962:61-67.
75. Samowska A., Braun H., Sauerzweig S., Reymann K.G. The neuroprotective effect of bone marrow stem cells is not dependent on direct cell contact with hypoxic injured tissue. Exp. Neurol. 2009, 215:317-327.
76. Sanders E.J., Baudet M.L., Parker E., Harvey S. Signaling mechanisms mediating local GH action in the neural retina of the chick embryo. Gen. Comp. Endocrinol. 2009, 163:63-69.
77. Savitz S.I. Introduction to cellular therapy: the next frontier for stroke therapeutics. Stroke 2009, 40(3 Suppl.):S141-S142.
78. Scheepens A., Sirimanne E., Beilharz E., Breier B.H., Waters M.J., Gluckman P.D., Williams C.E. Alterations in the neural growth hormone axis following hypoxic-ischemic brain injury. Brain Res. Mol. Brain Res. 1999, 68:88-100.
79. Scheepens A., Williams C.E., Breier B.H., Guan J., Gluckman P.D. A role for the somatotropic axis in neural development, injury and disease. J. Pediatr. Endocrinol. Metab. 2000, 13(Suppl. 6):1483-1491.
80. Scheepens A., Sirimanne E.S., Breier B.H., Clark R.G., Gluckman P.D., Williams C.E. Growth hormone as a neuronal rescue factor during recovery from CNS injury. Neuroscience 2001, 104:677-687.
81. Shiotani A., O'Malley B.W., Coleman M.E., Flint P.W. Human insulin-like growth factor 1 gene transfer into paralyzed rat larynx: single vs multiple injection. Arch. Otolaryngol. Head Neck Surg. 1999, 125:555-560.
82. Scott H.J., Stebbing M.J., Walters C.E., et al. Differential effects of SOCS2 on neuronal differentiation and morphology. Brain Res. 2006, 1067:138-145.
83. Silva C., Zhang K., Tsutsui S., Holden J.K., Gill M.J., Power C. Growth hormone prevents human immunodeficiency virus-induced neuronal p53 expression. Ann. Neurol. 2003, 54:605-614.
84. Sohmiya M., Kato Y. Effect of long-term administration of recombinant human growth hormone (rhGH) on plasma erythropoietin (EPO) and haemoglobin levels in anaemic patients with adult GH deficiency. Clin. Endocrinol. (Oxf) 2001, 55:749-754.
85. Sun L.Y., Al-Regaiey K., Masternak M.M., Wang J., Bartke A. Local expression of GH and IGF-1 in the hippocampus of GH-deficient long-lived mice. Neurobiol. Aging 2005, 26:929-937.
86. Sun L.Y., Evans M.S., Hsieh J., Panici J., Bartke A. Increased neurogenesis in dentate gyrus of long-lived Ames dwarf mice. Endocrinology 2005, 146:1138-1144.
87. Sun L.Y., Bartke A. Adult neurogenesis in the hippocampus of long-lived mice during aging. J. Gerontol. A Biol. Sci. Med. Sci. 2007, 62:117-125.
88. Sun D., Bullock M.R., Altememi N., Zhou Z., Hagood S., Rolfe A., McGinn M.J., Hamm R., Colello R.J. The effect of epidermal growth factor in the injured brain after trauma in rats. J. Neurotrauma 2010, 27:923-938.
89. Thomas-Stonell N., Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia 1988, 3:73-78.
90. Torres-Aleman I. Toward a comprehensive neurobiology of IGF-I. Dev. Neurobiol. 2010, 70:384-396.
91. Tsai P.T., Ohab J.J., Kertesz N., et al. A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J. Neurosci. 2006, 26:1269-1274.
92. Türeyen K., Vemuganti R., Bowen K.K., Sailor K.A., Dempsey R.J. EGF and FGF-2 infusion increases post-ischemic neural progenitor cell proliferation in the adult rat brain. Neurosurgery 2005, 57:1254-1263.
93. Turnley A.M., Faux C.H., Rietze R.L., Coonan J.R., Bartlett P.F. Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling. Nat. Neurosci. 2002, 5:1155-1162.
94. van Dam P.S. Somatotropin therapy and cognitive function in adults with growth hormone deficiency: a critical review. Treat. Endocrinol. 2006, 5:159-170.
95. van Marle G., Antony J.M., Silva C., Sullivan A., Power C. Aberrant cortical neurogenesis in a pediatric neuroAIDS model: neurotrophic effects of growth hormone. AIDS 2005, 19:1781-1791.
96. Woodson G.E. Spontaneous laryngeal reinnervation after recurrent laryngeal or vagus nerve injury. Ann. Otol. Rhinol. Laryngol. 2007, 116:57-65.
97. Yamauchi T., Ueki K., Tobe K., et al. Growth hormone-induced tyrosine phosphorylation of EGF receptor as an essential element leading to MAP kinase activation and gene expression. Endocr. J. 1998, 45:S27-S31. Suppl.
98. Yan H., Mitschelen M., Bixler G.V., et al. Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence. J. Endocrinol. 2011, 211:27-37.
99. Yang B., Strong R., Sharma S., et al. Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke. J. Neurosci. Res. 2011, 89:833-839.
100. Zhang R., Zhang Z., Wang L., et al. Activated neural stem cells contribute to stroke-induced neurogenesis and neuroblast migration toward the infarct boundary in adult rats. J. Cereb. Blood Flow Metab. 2004, 24:441-448.
101. Zhang L., Chopp M., Zhang R.L., et al. Erythropoietin amplifies stroke-induced oligodendrogenesis in the rat. PLoS One 2010, 5:e106.
102. BDIST.
103. FOAMS.
104. GMFM.
105. Intelligibility test.
106. MMSE.
107. WAIS.